Editorial: Lung adenocarcinoma: from genomics to immunotherapy
- PMID: 38655051
- PMCID: PMC11036335
- DOI: 10.3389/fgene.2024.1399127
Editorial: Lung adenocarcinoma: from genomics to immunotherapy
Keywords: cancer biomarkers; cancer prognosis; disease monitoring; lung cancer; precision medicine; solid cancer.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Lung adenocarcinoma: from genomics to immunotherapy
References
Publication types
LinkOut - more resources
Full Text Sources